These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35110645)

  • 21. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
    Falsey AR; Sobieszczyk ME; Hirsch I; Sproule S; Robb ML; Corey L; Neuzil KM; Hahn W; Hunt J; Mulligan MJ; McEvoy C; DeJesus E; Hassman M; Little SJ; Pahud BA; Durbin A; Pickrell P; Daar ES; Bush L; Solis J; Carr QO; Oyedele T; Buchbinder S; Cowden J; Vargas SL; Guerreros Benavides A; Call R; Keefer MC; Kirkpatrick BD; Pullman J; Tong T; Brewinski Isaacs M; Benkeser D; Janes HE; Nason MC; Green JA; Kelly EJ; Maaske J; Mueller N; Shoemaker K; Takas T; Marshall RP; Pangalos MN; Villafana T; Gonzalez-Lopez A;
    N Engl J Med; 2021 Dec; 385(25):2348-2360. PubMed ID: 34587382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
    de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
    Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon
    Byazrova MG; Kulemzin SV; Astakhova EA; Belovezhets TN; Efimov GA; Chikaev AN; Kolotygin IO; Gorchakov AA; Taranin AV; Filatov AV
    Front Immunol; 2022; 13():840707. PubMed ID: 35280987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
    Jeewandara C; Aberathna IS; Danasekara S; Gomes L; Fernando S; Guruge D; Ranasinghe T; Gunasekera B; Kamaladasa A; Kuruppu H; Somathilake G; Jayamali J; Jayathilaka D; Wijayatilake HDK; Pushpakumara PD; Harvie M; Nimasha T; de Silva SDG; Wijayamuni R; Schimanski L; Rijal P; Tan J; Townsend A; Ogg GS; Malavige GN
    Immunology; 2022 Oct; 167(2):263-274. PubMed ID: 35751563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Emary KRW; Golubchik T; Aley PK; Ariani CV; Angus B; Bibi S; Blane B; Bonsall D; Cicconi P; Charlton S; Clutterbuck EA; Collins AM; Cox T; Darton TC; Dold C; Douglas AD; Duncan CJA; Ewer KJ; Flaxman AL; Faust SN; Ferreira DM; Feng S; Finn A; Folegatti PM; Fuskova M; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hallis B; Heath PT; Hay J; Hill HC; Jenkin D; Kerridge S; Lazarus R; Libri V; Lillie PJ; Ludden C; Marchevsky NG; Minassian AM; McGregor AC; Mujadidi YF; Phillips DJ; Plested E; Pollock KM; Robinson H; Smith A; Song R; Snape MD; Sutherland RK; Thomson EC; Toshner M; Turner DPJ; Vekemans J; Villafana TL; Williams CJ; Hill AVS; Lambe T; Gilbert SC; Voysey M; Ramasamy MN; Pollard AJ; ; ;
    Lancet; 2021 Apr; 397(10282):1351-1362. PubMed ID: 33798499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
    Ewer KJ; Barrett JR; Belij-Rammerstorfer S; Sharpe H; Makinson R; Morter R; Flaxman A; Wright D; Bellamy D; Bittaye M; Dold C; Provine NM; Aboagye J; Fowler J; Silk SE; Alderson J; Aley PK; Angus B; Berrie E; Bibi S; Cicconi P; Clutterbuck EA; Chelysheva I; Folegatti PM; Fuskova M; Green CM; Jenkin D; Kerridge S; Lawrie A; Minassian AM; Moore M; Mujadidi Y; Plested E; Poulton I; Ramasamy MN; Robinson H; Song R; Snape MD; Tarrant R; Voysey M; Watson MEE; Douglas AD; Hill AVS; Gilbert SC; Pollard AJ; Lambe T;
    Nat Med; 2021 Feb; 27(2):270-278. PubMed ID: 33335323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression.
    Prendecki M; Clarke C; Edwards H; McIntyre S; Mortimer P; Gleeson S; Martin P; Thomson T; Randell P; Shah A; Singanayagam A; Lightstone L; Cox A; Kelleher P; Willicombe M; McAdoo SP
    Ann Rheum Dis; 2021 Oct; 80(10):1322-1329. PubMed ID: 34362747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries.
    Romero-Ibarguengoitia ME; González-Cantú A; Pozzi C; Levi R; Mollura M; Sarti R; Sanz-Sánchez MÁ; Rivera-Salinas D; Hernández-Ruíz YG; Armendariz-Vázquez AG; Del Rio-Parra GF; Barco-Flores IA; González-Facio R; Azzolini E; Barbieri R; de Azevedo Dias AR; Henriques Guimarães Júnior M; Bastos-Borges A; Acciardi C; Paez-Bo G; Teixeira MM; Rescigno M
    Front Immunol; 2022; 13():894277. PubMed ID: 35967368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
    Frater J; Ewer KJ; Ogbe A; Pace M; Adele S; Adland E; Alagaratnam J; Aley PK; Ali M; Ansari MA; Bara A; Bittaye M; Broadhead S; Brown A; Brown H; Cappuccini F; Cooney E; Dejnirattisai W; Dold C; Fairhead C; Fok H; Folegatti PM; Fowler J; Gibbs C; Goodman AL; Jenkin D; Jones M; Makinson R; Marchevsky NG; Mujadidi YF; Nguyen H; Parolini L; Petersen C; Plested E; Pollock KM; Ramasamy MN; Rhead S; Robinson H; Robinson N; Rongkard P; Ryan F; Serrano S; Tipoe T; Voysey M; Waters A; Zacharopoulou P; Barnes E; Dunachie S; Goulder P; Klenerman P; Screaton GR; Winston A; Hill AVS; Gilbert SC; Pollard AJ; Fidler S; Fox J; Lambe T;
    Lancet HIV; 2021 Aug; 8(8):e474-e485. PubMed ID: 34153264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 32. Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
    Rossi AH; Ojeda DS; Varese A; Sanchez L; Gonzalez Lopez Ledesma MM; Mazzitelli I; Alvarez Juliá A; Oviedo Rouco S; Pallarés HM; Costa Navarro GS; Rasetto NB; Garcia CI; Wenker SD; Ramis LY; Bialer MG; de Leone MJ; Hernando CE; Sosa S; Bianchimano L; Rios AS; Treffinger Cienfuegos MS; Caramelo JJ; Longueira Y; Laufer N; Alvarez DE; Carradori J; Pedrozza D; Rima A; Echegoyen C; Ercole R; Gelpi P; Marchetti S; Zubieta M; Docena G; Kreplak N; Yanovsky M; Geffner J; Pifano M; Gamarnik AV
    Cell Rep Med; 2021 Aug; 2(8):100359. PubMed ID: 34308389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    Saadat S; Rikhtegaran Tehrani Z; Logue J; Newman M; Frieman MB; Harris AD; Sajadi MM
    JAMA; 2021 Apr; 325(14):1467-1469. PubMed ID: 33646292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant.
    Fumagalli MJ; Castro-Jorge LA; de Souza WM; de Azevedo PO; Hansen AW; Gazzinelli RT; da Fonseca BAL; Spilki FR; Figueiredo LTM
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Pegu A; O'Connell SE; Schmidt SD; O'Dell S; Talana CA; Lai L; Albert J; Anderson E; Bennett H; Corbett KS; Flach B; Jackson L; Leav B; Ledgerwood JE; Luke CJ; Makowski M; Nason MC; Roberts PC; Roederer M; Rebolledo PA; Rostad CA; Rouphael NG; Shi W; Wang L; Widge AT; Yang ES; ; Beigel JH; Graham BS; Mascola JR; Suthar MS; McDermott AB; Doria-Rose NA; Arega J; Beigel JH; Buchanan W; Elsafy M; Hoang B; Lampley R; Kolhekar A; Koo H; Luke C; Makhene M; Nayak S; Pikaart-Tautges R; Roberts PC; Russell J; Sindall E; Albert J; Kunwar P; Makowski M; Anderson EJ; Bechnak A; Bower M; Camacho-Gonzalez AF; Collins M; Drobeniuc A; Edara VV; Edupuganti S; Floyd K; Gibson T; Ackerley CMG; Johnson B; Kamidani S; Kao C; Kelley C; Lai L; Macenczak H; McCullough MP; Peters E; Phadke VK; Rebolledo PA; Rostad CA; Rouphael N; Scherer E; Sherman A; Stephens K; Suthar MS; Teherani M; Traenkner J; Winston J; Yildirim I; Barr L; Benoit J; Carste B; Choe J; Dunstan M; Erolin R; Ffitch J; Fields C; Jackson LA; Kiniry E; Lasicka S; Lee S; Nguyen M; Pimienta S; Suyehira J; Witte M; Bennett H; Altaras NE; Carfi A; Hurley M; Leav B; Pajon R; Sun W; Zaks T; Coler RN; Larsen SE; Neuzil KM; Lindesmith LC; Martinez DR; Munt J; Mallory M; Edwards C; Baric RS; Berkowitz NM; Boritz EA; Carlton K; Corbett KS; Costner P; Creanga A; Doria-Rose NA; Douek DC; Flach B; Gaudinski M; Gordon I; Graham BS; Holman L; Ledgerwood JE; Leung K; Lin BC; Louder MK; Mascola JR; McDermott AB; Morabito KM; Novik L; O'Connell S; O'Dell S; Padilla M; Pegu A; Schmidt SD; Shi W; Swanson PA; Talana CA; Wang L; Widge AT; Yang ES; Zhang Y; Chappell JD; Denison MR; Hughes T; Lu X; Pruijssers AJ; Stevens LJ; Posavad CM; Gale M; Menachery V; Shi PY
    Science; 2021 Sep; 373(6561):1372-1377. PubMed ID: 34385356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Kuhlmann C; Mayer CK; Claassen M; Maponga T; Burgers WA; Keeton R; Riou C; Sutherland AD; Suliman T; Shaw ML; Preiser W
    Lancet; 2022 Feb; 399(10325):625-626. PubMed ID: 35063123
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    Madhi SA; Baillie V; Cutland CL; Voysey M; Koen AL; Fairlie L; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Kwatra G; Ahmed K; Aley P; Bhikha S; Bhiman JN; Bhorat AE; du Plessis J; Esmail A; Groenewald M; Horne E; Hwa SH; Jose A; Lambe T; Laubscher M; Malahleha M; Masenya M; Masilela M; McKenzie S; Molapo K; Moultrie A; Oelofse S; Patel F; Pillay S; Rhead S; Rodel H; Rossouw L; Taoushanis C; Tegally H; Thombrayil A; van Eck S; Wibmer CK; Durham NM; Kelly EJ; Villafana TL; Gilbert S; Pollard AJ; de Oliveira T; Moore PL; Sigal A; Izu A; ;
    N Engl J Med; 2021 May; 384(20):1885-1898. PubMed ID: 33725432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
    Szebeni GJ; Gémes N; Honfi D; Szabó E; Neuperger P; Balog JÁ; Nagy LI; Szekanecz Z; Puskás LG; Toldi G; Balog A
    Front Immunol; 2022; 13():846248. PubMed ID: 35432314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
    Shen CF; Yen CL; Fu YC; Cheng CM; Shen TC; Chang PD; Cheng KH; Liu CC; Chang YT; Chen PL; Ko WC; Shieh CC
    Front Immunol; 2022; 13():807454. PubMed ID: 35145520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.